The U.S. National Nanotechnology Initiative has updated its Environmental Health and Safety strategy to address ongoing challenges and emerging nanotechnology applications. The strategy emphasises responsible innovation and highlights the need for collaborative actions to address concerns related to the impact of engineered nanomaterials on human health and the environment.

Scientists from the public, private and philanthropic sectors involved in the Nano4EARTH initiative have identified key research directions to maximise the impact of nanotechnology in addressing climate change. They focus on enhancing energy storage, reducing industrial carbon emissions and improving efficiency in industrial processes.

Lipid nanoparticles (LNPs) are a groundbreaking delivery system for mRNA vaccines, such as those used for COVID-19. Now, they are pivotal in developing a range of new vaccines and gene therapies. The European Medicines Agency (EMA) and the European Pharmacopoeia are actively updating guidelines and quality requirements to ensure the safe and effective use of LNP-based medicine.

A recent EU ON opinion highlights the potential of advanced materials to support sustainability goals while acknowledging their human health and environmental risks. The European Commission’s 2024 communication emphasises the need for Safe-and-Sustainable-by-Design (SSbD) principles to ensure safety and sustainability.

The degradation of two-dimensional (2D) materials throughout their life cycle can result in the formation of degradation products with different properties and effects on human health and the environment than the original materials.

Two recent studies have proposed new methods to detect the presence of nanoparticles in food and cosmetics. The first study suggests a two-step approach to detect the banned food additive E 171. This involves screening for elemental titanium, followed by detecting nano-sized titanium dioxide. The second study used a quick screening tool to identify the presence of seven different nanoparticles in facial cosmetics. However, both methods have only been partially validated, and further improvements are required. There is a lack of reliable data on background titanium concentrations in food. A lack of reference matrices with known amounts of nanoparticles in consumer products is another challenge that needs to be addressed.

The use of Artificial Intelligence (AI) applications is quickly increasing and has the potential to revolutionize chemical risk assessment. For predicting the toxicity of nanomaterials, current models only work for relatively simple nanomaterials. There is a need to anticipate current developments and strategies to prepare for future AI implementation in chemical regulation.

Researchers from the EU Graphene Flagship have highlighted the complexity of assessing the safety of graphene and related materials. Such assessment requires detailed knowledge of safety-related physicochemical properties and the development of harmonised test methods. These lessons must receive ample attention in future innovation programmes on new materials.

By 2023, two European research projects related to the Malta Initiative were completed: Gov4Nano and NanoHarmony. These projects provided scientific support to thirteen OECD projects aimed at developing or modifying OECD Test Guidelines or Guidance Documents. However, more work is needed to finalise the OECD documents. The Malta Initiative has also identified further needs for harmonised test methods for future (advanced) materials and animal-free safety testing. The NanoHarmony White Paper guides on how to continue developing these test methods. However, it is uncertain how to identify and address future needs in the absence of resources for funding.

The safety of fullerenes in cosmetic products is uncertain, according to the EU Scientific Committee on Consumer Safety (SCCS). The information provided by the Notifier on the possible genotoxicity of fullerenes and other concerns was insufficient. The European Commission has recently proposed a new rule requiring the industry to provide additional data in the short term. If the industry fails to do so, fullerenes will be banned for use in cosmetic products, like other nanomaterials.